These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 6427702)

  • 1. Serotyping of meningococci by coagglutination with monoclonal antibodies.
    Frøholm LO; Bøvre K; Holten E; Zollinger WD
    NIPH Ann; 1983 Dec; 6(2):125-31. PubMed ID: 6427702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monoclonal antibodies to serotype 2 and serotype 15 outer membrane proteins of Neisseria meningitidis and their use in serotyping.
    Zollinger WD; Moran EE; Connelly H; Mandrell RE; Brandt B
    Infect Immun; 1984 Oct; 46(1):260-6. PubMed ID: 6434428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serotype antigens of Neisseria meningitidis and a proposed scheme for designation of serotypes.
    Frasch CE; Zollinger WD; Poolman JT
    Rev Infect Dis; 1985; 7(4):504-10. PubMed ID: 2412271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serotyping and subtyping of Neisseria meningitidis isolates by co-agglutination, dot-blotting and ELISA.
    Wedege E; Høiby EA; Rosenqvist E; Frøholm LO
    J Med Microbiol; 1990 Mar; 31(3):195-201. PubMed ID: 2107317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sero-subtyping of group B, C, Y and A meningococci isolated in France in 1988.
    Riou JY; Poolman JT; Auriol J; Lomprez F; Guibourdenche M
    Ann Biol Clin (Paris); 1990; 48(4):227-31. PubMed ID: 2113783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of class 5 antigens by meningococcal strains obtained from patients in Brazil and evaluation of two new monoclonal antibodies.
    De Gaspari E; Zollinger W
    Braz J Infect Dis; 2001 Jun; 5(3):143-53. PubMed ID: 11506778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new variant of serosubtype P1.16 in Neisseria meningitidis from Norway, associated with increased resistance to bactericidal antibodies induced by a serogroup B outer membrane protein vaccine.
    Rosenqvist E; Høiby EA; Wedege E; Caugant DA; Frøholm LO; McGuinness BT; Brooks J; Lambden PR; Heckels JE
    Microb Pathog; 1993 Sep; 15(3):197-205. PubMed ID: 7505873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serogroup determination of Neisseria meningitidis by whole-cell ELISA, dot-blotting and agglutination.
    Rosenqvist E; Wedege E; Høiby EA; Frøholm LO
    APMIS; 1990 Jun; 98(6):501-6. PubMed ID: 2116811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neisseria meningitidis: serotyping and subtyping by whole cell ELISA.
    Prakash K; Lakshmy A; Malhotra VL
    Br J Biomed Sci; 1993 Sep; 50(3):174-7. PubMed ID: 8241833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Meningococcal group B vaccine trial in Norway 1981--1982. Preliminary report of results available November 1982.
    Frøholm LO; Berdal BP; Bøvre K; Gaustad P; Harboe A; Holten E; Høiby EA; Lystad A; Omland T; Frasch CE
    NIPH Ann; 1983 Dec; 6(2):133-8. PubMed ID: 6427703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two monoclonal antibodies specific for serotype 4 antigen of Neisseria meningitidis.
    Abdillahi H; Crowe BA; Achtman M; Poolman JT
    Eur J Clin Microbiol Infect Dis; 1988 Apr; 7(2):293-6. PubMed ID: 2455642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Typing of group-B Neisseria meningitidis with monoclonal antibodies in the whole-cell ELISA.
    Abdillahi H; Poolman JT
    J Med Microbiol; 1988 Jul; 26(3):177-80. PubMed ID: 3134550
    [No Abstract]   [Full Text] [Related]  

  • 13. Expression of an inaccessible P1.7 subtype epitope on meningococcal class 1 proteins.
    Wedege E; Dalseg R; Caugant DA; Poolman JT; Frøholm LO
    J Med Microbiol; 1993 Jan; 38(1):23-8. PubMed ID: 7678117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Production of monoclonal antibody to subtype 9 of Neisseria meningitidis and the distribution of this subtype in Brazil.
    Belo EF; Coutinho LM; Ferraz AS; De Gaspari EN
    Braz J Infect Dis; 2004 Dec; 8(6):407-18. PubMed ID: 15880231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Definition of meningococcal class 1 OMP subtyping antigens by monoclonal antibodies.
    Abdillahi H; Poolman JT
    FEMS Microbiol Immunol; 1988 Dec; 1(3):139-44. PubMed ID: 3152545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neisseria meningitidis group B serosubtyping using monoclonal antibodies in whole-cell ELISA.
    Abdillahi H; Poolman JT
    Microb Pathog; 1988 Jan; 4(1):27-32. PubMed ID: 3143890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New serotype candidate of Neisseria meningitidis.
    Krízová P; Musílek M; Danielová V; Holubová J
    Cent Eur J Public Health; 1996 Sep; 4(3):169-72. PubMed ID: 8884051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protection against infection with Neisseria meningitidis group B serotype 2b by passive immunization with serotype-specific monoclonal antibody.
    Brodeur BR; Larose Y; Tsang P; Hamel J; Ashton F; Ryan A
    Infect Immun; 1985 Nov; 50(2):510-6. PubMed ID: 3932211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emergence of a new virulent clone within the electrophoretic type 5 complex of serogroup B meningococci in Norway.
    Wedege E; Kolberg J; Delvig A; Høiby EA; Holten E; Rosenqvist E; Caugant DA
    Clin Diagn Lab Immunol; 1995 May; 2(3):314-21. PubMed ID: 7664178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunization with meningococcal outer-membrane protein vesicles containing lipooligosaccharide protects mice against lethal experimental group B Neisseria meningitidis infection and septic shock.
    Quakyi EK; Frasch CE; Buller N; Tsai CM
    J Infect Dis; 1999 Sep; 180(3):747-54. PubMed ID: 10438363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.